Prosecution Insights
Last updated: May 29, 2026

Flagship Pioneering Innovations Vi LLC

24 pending office actions • 14 art units • 20 examiners • 0 of 24 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Portfolio Summary

24
Total Pending OAs
14
Non-Final OAs
10
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

16
Overdue
3
Due this week
3
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (16)Due ≤ 7 days (3)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
14
Medium (58%)
1
Easy (4%)
9
Unknown (38%)

Rejection Statute Mix

BucketCases
§103 only12 (50%)
§102 only1 (4%)
§112 only1 (4%)
Double-patenting + other1 (4%)
No statute on record9 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

23
Life Sciences
96% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
4% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEITH, NANCY J 2 74.7% +43.8%
DAUNER, JOSEPH G 2 56.8% +34.8%
KIM, TAEYOON 2 51.5% +51.4%
ZAHORIK, AMANDA MARY 2 60.9% +52.6%
SKIBINSKY, ANNA 1 38.8% +29.2%
LIN, JERRY 1 72.3% +15.2%
PAULS, JOHN A 1 48.7% +27.3%
PERSONS, JENNA L 1 52.8% +65.0%
FOLEY, SHANON A 1 73.7% +18.1%
SCHACHERMEYER, SAMANTHA LYNN 1 36.7% +65.0%

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19272711 METHODS AND COMPOSITIONS FOR MODULATING A GENOME LEITH, NANCY J 89d overdue
19272775 METHODS AND COMPOSITIONS FOR MODULATING A GENOME LEITH, NANCY J 86d overdue
19288411 MULTI-TIERED TESTING FOR TRACKING DISEASE HETEROGENEITY SKIBINSKY, ANNA 50d overdue
18469344 SERPINA-MODULATING COMPOSITIONS AND METHODS PERSONS, JENNA L 49d overdue
18011832 ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME SCHACHERMEYER, SAMANTHA LYNN 31d overdue
17433658 COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES KIM, TAEYOON 29d overdue
18945759 SYSTEMS AND METHODS FOR PATIENT TARGETED THERAPY DEVELOPMENT PAULS, JOHN A 23d overdue
19287260 MULTIPLE-TIERED SCREENING AND DIAGNOSTIC ANALYSIS LIN, JERRY 8d overdue

Top Art Units

Art UnitApps
1636 5
1635 2
1682 2
1637 2
1631 2
1633 2
1687 2
1685 1
3683 1
1671 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19288411 MULTI-TIERED TESTING FOR TRACKING DISEASE HETEROGENEITY SKIBINSKY, ANNA 1635 §103 Final Rejection 50d overdue Pending Aug 01, 2025
19287260 MULTIPLE-TIERED SCREENING AND DIAGNOSTIC ANALYSIS LIN, JERRY 1685 Other Non-Final OA 8d overdue Pending Jul 31, 2025
19272711 METHODS AND COMPOSITIONS FOR MODULATING A GENOME LEITH, NANCY J 1636 Other Non-Final OA 89d overdue Pending Jul 17, 2025
19272775 METHODS AND COMPOSITIONS FOR MODULATING A GENOME LEITH, NANCY J 1636 Other Non-Final OA 86d overdue Pending Jul 17, 2025
18945759 SYSTEMS AND METHODS FOR PATIENT TARGETED THERAPY DEVELOPMENT PAULS, JOHN A 3683 Other Non-Final OA 23d overdue Pending Nov 13, 2024
18444227 COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY DAUNER, JOSEPH G 1682 §103 Final Rejection 2d overdue Pending Feb 16, 2024
18474060 COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY DAUNER, JOSEPH G 1682 DPOther Non-Final OA 70d Pending Sep 25, 2023
18469344 SERPINA-MODULATING COMPOSITIONS AND METHODS PERSONS, JENNA L 1637 Other Final Rejection 49d overdue Pending Sep 18, 2023
18038630 ADIPOGENIC CELL COMPOSITIONS AND METHODS KIM, TAEYOON 1631 §102 Non-Final OA 13d Pending May 24, 2023
18024542 IMMUNOGENIC COMPOSITIONS AND USES THEREOF FOLEY, SHANON A 1671 §103 Final Rejection 22d Pending Mar 03, 2023
18011832 ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME SCHACHERMEYER, SAMANTHA LYNN 1693 §103 Final Rejection 31d overdue Pending Dec 20, 2022
18010857 METHODS AND COMPOSITIONS FOR MODULATING CELLS AND CELLULAR MEMBRANES RAHMAN, MASUDUR 1633 §103 Non-Final OA 36d Pending Dec 17, 2022
17925920 CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES BUCKMASTER, MARLENE VRENI 1672 §103 Non-Final OA 10d overdue Pending Nov 17, 2022
17929124 METHODS AND COMPOSITIONS FOR MODULATING A GENOME LEE, JAE W 1656 §103 Non-Final OA 6d Pending Sep 01, 2022
17795915 COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOF PYLA, EVELYN Y 1633 §103 Non-Final OA 16d overdue Pending Jul 28, 2022
17795943 DELIVERY OF COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES WHITEMAN, BRIAN A 1636 Other Final Rejection 6d Pending Jul 28, 2022
17792639 MOLECULE DESIGN SANFORD, DIANA PATRICIA 1687 §103 Non-Final OA 23d overdue Pending Jul 13, 2022
17749788 RECOMBINASE COMPOSITIONS AND METHODS OF USE NOBLE, MARCIA STEPHENS 1632 Other Non-Final OA 23d overdue Pending May 20, 2022
17756211 Protein Structure Prediction AUGER, NOAH ANDREW 1687 §103 Non-Final OA 36d overdue Pending May 19, 2022
17577942 RECOMBINASE COMPOSITIONS AND METHODS OF USE MCLEOD, AFRICA MHAIRIE 1635 §112 Final Rejection 21d Pending Jan 18, 2022
17433658 COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES KIM, TAEYOON 1631 Other Final Rejection 29d overdue Pending Aug 25, 2021
17433655 POLYRIBONUCLEOTIDES AND COSMETIC USES THEREOF LIPPOLIS, ALEXANDRA ROSE 1637 Other Final Rejection 31d overdue Pending Aug 25, 2021
17433639 CIRCULAR POLYRIBONUCLEOTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF ZAHORIK, AMANDA MARY 1636 §103 Non-Final OA 8d overdue Pending Aug 25, 2021
17262591 COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF ZAHORIK, AMANDA MARY 1636 §103 Final Rejection 7d Pending Jan 22, 2021

Managing Flagship Pioneering Innovations Vi LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month